chr10-121515280-T-C
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_022970.4(FGFR2):c.1127A>G(p.Tyr376Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y376F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_022970.4 missense
Scores
Clinical Significance
Conservation
Publications
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000457416.7 | c.1127A>G | p.Tyr376Cys | missense_variant | Exon 9 of 18 | 1 | NM_022970.4 | ENSP00000410294.2 | ||
| FGFR2 | ENST00000358487.10 | c.1124A>G | p.Tyr375Cys | missense_variant | Exon 9 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
| FGFR2 | ENST00000369056.5 | c.1127A>G | p.Tyr376Cys | missense_variant | Exon 8 of 17 | 1 | ENSP00000358052.1 | |||
| FGFR2 | ENST00000369058.7 | c.1127A>G | p.Tyr376Cys | missense_variant | Exon 9 of 17 | 1 | ENSP00000358054.3 | |||
| FGFR2 | ENST00000613048.4 | c.857A>G | p.Tyr286Cys | missense_variant | Exon 8 of 17 | 5 | ENSP00000484154.1 | |||
| FGFR2 | ENST00000369061.8 | c.788A>G | p.Tyr263Cys | missense_variant | Exon 6 of 15 | 1 | ENSP00000358057.4 | |||
| FGFR2 | ENST00000369059.5 | c.782A>G | p.Tyr261Cys | missense_variant | Exon 7 of 16 | 5 | ENSP00000358055.1 | |||
| FGFR2 | ENST00000360144.7 | c.860A>G | p.Tyr287Cys | missense_variant | Exon 8 of 17 | 2 | ENSP00000353262.3 | |||
| FGFR2 | ENST00000478859.5 | c.440A>G | p.Tyr147Cys | missense_variant | Exon 8 of 17 | 1 | ENSP00000474011.1 | |||
| FGFR2 | ENST00000604236.5 | n.*171A>G | non_coding_transcript_exon_variant | Exon 8 of 17 | 1 | ENSP00000474109.1 | ||||
| FGFR2 | ENST00000604236.5 | n.*171A>G | 3_prime_UTR_variant | Exon 8 of 17 | 1 | ENSP00000474109.1 | ||||
| FGFR2 | ENST00000429361.5 | c.-101A>G | upstream_gene_variant | 5 | ENSP00000404219.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Beare-Stevenson cutis gyrata syndrome Pathogenic:5
Recurrent pathogenic: RCV000762799 -
- -
- -
- -
- -
not provided Pathogenic:3
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12000365, 12900900, 23754559, 16531735, 25937001, 17525745, 19610084, 12145519, 27079505, 21397175, 17449949, 35050789, 32158469, 21479481, 8696350, 9545103, 25706251, 20856019) -
- -
- -
FGFR2-related craniosynostosis Pathogenic:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 375 of the FGFR2 protein (p.Tyr375Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Beare-Stevenson cutis gyrata syndrome (PMID: 8696350, 12145519, 12900900, 16531735, 20856019, 21397175, 25706251, 25937001, 27079505). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 13277). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FGFR2 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
FGFR2-related disorder Pathogenic:1
The FGFR2 c.1124A>G variant is predicted to result in the amino acid substitution p.Tyr375Cys. This variant has been well documented to be pathogenic for Beare-Stevenson cutis gyrata syndrome (see for example Przylepa et al. 1996. PubMed ID: 8696350; Fonseca et al. 2008. PubMed ID: 21479481; Wenger et al. 2015. PMID: 25706251; Ron et al. 2016. PubMed ID: 27079505). This variant has also been identified as a de novo variant in an infant with a clinical diagnosis of Pfeiffer syndrome (Willig et al. 2015. PubMed ID: 25937001). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
Acrocephalosyndactyly type I;C0010273:Crouzon syndrome;C0038356:Neoplasm of stomach;C0175699:Saethre-Chotzen syndrome;C0220658:Pfeiffer syndrome;C0265269:Levy-Hollister syndrome;C0795998:Jackson-Weiss syndrome;C1852406:Beare-Stevenson cutis gyrata syndrome;C1865070:Familial scaphocephaly syndrome, McGillivray type;C2936791:Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;C3281247:Bent bone dysplasia syndrome 1 Pathogenic:1
- -
Endometrial carcinoma Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at